Exact Therapeutics (Norway) Market Value
| EXTX Stock | NOK 5.70 0.10 1.72% |
| Symbol | Exact |
Exact Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Exact Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Exact Therapeutics.
| 10/28/2024 |
| 11/27/2024 |
If you would invest 0.00 in Exact Therapeutics on October 28, 2024 and sell it all today you would earn a total of 0.00 from holding Exact Therapeutics AS or generate 0.0% return on investment in Exact Therapeutics over 30 days. Exact Therapeutics is related to or competes with River Tech, Helgeland Sparebank, Aurskog Sparebank, Napatech, Lea Bank, Aasen Sparebank, and Nordic Technology. EXACT Therapeutics AS, a clinical stage biotech company, develops a technology platform for targeted therapeutic enhance... More
Exact Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Exact Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Exact Therapeutics AS upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 23.62 | |||
| Value At Risk | (3.85) | |||
| Potential Upside | 4.0 |
Exact Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Exact Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Exact Therapeutics' standard deviation. In reality, there are many statistical measures that can use Exact Therapeutics historical prices to predict the future Exact Therapeutics' volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.09) | |||
| Total Risk Alpha | (0.57) | |||
| Treynor Ratio | (0.59) |
Exact Therapeutics Backtested Returns
Exact Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0237, which denotes the company had a -0.0237% return per unit of standard deviation over the last 3 months. Exact Therapeutics AS exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Exact Therapeutics' Standard Deviation of 3.21, coefficient of variation of (5,137), and Mean Deviation of 1.14 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.12, which means not very significant fluctuations relative to the market. As returns on the market increase, Exact Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Exact Therapeutics is expected to be smaller as well. At this point, Exact Therapeutics has a negative expected return of -0.0772%. Please make sure to confirm Exact Therapeutics' mean deviation, information ratio, potential upside, as well as the relationship between the standard deviation and total risk alpha , to decide if Exact Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.00 |
No correlation between past and present
Exact Therapeutics AS has no correlation between past and present. Overlapping area represents the amount of predictability between Exact Therapeutics time series from 28th of October 2024 to 12th of November 2024 and 12th of November 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Exact Therapeutics price movement. The serial correlation of 0.0 indicates that just 0.0% of current Exact Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | -0.15 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Exact Therapeutics lagged returns against current returns
Autocorrelation, which is Exact Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Exact Therapeutics' stock expected returns. We can calculate the autocorrelation of Exact Therapeutics returns to help us make a trade decision. For example, suppose you find that Exact Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Exact Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Exact Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Exact Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Exact Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Exact Therapeutics Lagged Returns
When evaluating Exact Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Exact Therapeutics stock have on its future price. Exact Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Exact Therapeutics autocorrelation shows the relationship between Exact Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Exact Therapeutics AS.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Exact Stock
Exact Therapeutics financial ratios help investors to determine whether Exact Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Exact with respect to the benefits of owning Exact Therapeutics security.